ENGLE STEVEN B 4

4 · LA JOLLA PHARMACEUTICAL CO · Filed Nov 12, 2003

Form 4

Period: 2003-11-10

DirectorCEO & Chairman

Transactions

Exercise/Conversion
Stock Options (right to buy)
2003-11-10$1.00/sh−10,000$10,000→ 2,480,000 total
Exercise: $1.00Exp: 2004-02-02→ Common Stock (10,000 underlying)
Exercise/Conversion
Stock Options (right to buy)
2003-11-11$1.00/sh−31,000$31,000→ 2,449,000 total
Exercise: $1.00Exp: 2004-02-02→ Common Stock (31,000 underlying)
Exercise/Conversion
Common Stock
2003-11-10$1.00/sh+100,000$100,000→ 101,484 total
Exercise/Conversion
Common Stock
2003-11-10$1.00/sh+10,000$10,000→ 111,484 total
Sale
Common Stock
2003-11-10$3.02/sh−110,000$332,200→ 1,484 total
Exercise/Conversion
Common Stock
2003-11-11$1.00/sh+31,000$31,000→ 32,484 total
Sale
Common Stock
2003-11-11$2.93/sh−31,000$90,830→ 1,484 total
Exercise/Conversion
Stock Options (right to buy)
2003-11-10$1.00/sh−100,000$100,000→ 2,490,000 total
Exercise: $1.00Exp: 2004-01-04→ Common Stock (100,000 underlying)

Footnotes (3)

[F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 30, 2002, and amended on October 1, 2003.
[F2]Stock options became fully vested and exercisable on 01/04/1998.
[F3]Stock options became fully vested and exercisable on 02/02/1997.

Documents

1 file